Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
filingDate |
2007-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28fb8a9edefb8227b413e1377f9db32b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f96f51b5214f8089f8961d580d6cb2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10843e1a69b88cdca739d49c3a92f7e0 |
publicationDate |
2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-574194-A |
titleOfInvention |
Crystal form of epothilone b and use in pharmaceutical compositions |
abstract |
Disclosed herein is a crystal form of epothilone B having the reference modification C, which is characterised by X-ray diffraction with strong intensity at 17.5 and 18.3. Also disclosed are processes for its preparation, compositions comprising said crystal form and the use thereof in the preparation of a medicament for treating a proliferative disease. |
priorityDate |
2006-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |